LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 41.11 | 27.76 | 2177 | 3331 | 0.6535 | 0.8805 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 41.11 | 27.76 | 382 | 3331 | 0.1147 | 0.4617 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 41.11 | 27.76 | 2101 | 3331 | 0.6307 | 0.8709 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 42.81 | 27.76 | 21 | 3596 | 0.0058 | -0.0390 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 42.81 | 27.76 | 2307 | 3596 | 0.6415 | 0.8774 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 42.81 | 27.76 | 437 | 3596 | 0.1215 | 0.4811 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 42.81 | 27.76 | 2218 | 3596 | 0.6168 | 0.8669 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 44.52 | 27.76 | 21 | 3884 | 0.0054 | -0.0384 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 44.52 | 27.76 | 2469 | 3884 | 0.6356 | 0.8768 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 44.52 | 27.76 | 507 | 3884 | 0.1305 | 0.5031 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 44.52 | 27.76 | 2402 | 3884 | 0.6184 | 0.8696 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 46.22 | 27.76 | 37 | 4125 | 0.0090 | 0.0406 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 46.22 | 27.76 | 2714 | 4125 | 0.6579 | 0.8873 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 46.22 | 27.76 | 539 | 4125 | 0.1307 | 0.5085 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 46.22 | 27.76 | 2561 | 4125 | 0.6209 | 0.8721 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 47.93 | 27.76 | 49 | 4421 | 0.0111 | 0.0808 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 47.93 | 27.76 | 2921 | 4421 | 0.6607 | 0.8898 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 47.93 | 27.76 | 623 | 4421 | 0.1409 | 0.5300 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 47.93 | 27.76 | 2764 | 4421 | 0.6251 | 0.8756 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 49.63 | 27.76 | 60 | 4818 | 0.0125 | 0.1092 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 49.63 | 27.76 | 3150 | 4818 | 0.6538 | 0.8890 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 49.63 | 27.76 | 728 | 4818 | 0.1511 | 0.5513 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 49.63 | 27.76 | 2948 | 4818 | 0.6119 | 0.8722 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 51.33 | 27.76 | 77 | 5117 | 0.0150 | 0.1452 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 51.33 | 27.76 | 3379 | 5117 | 0.6603 | 0.8927 | MN20160318_Q01 | I13 |